STEAP1, a PCa membrane protein, not only demonstrates potential as a sensitive biomarker for cancer detection through plasma EVs or molecular imaging examinations but also demonstrates promising therapeutic utility via direct or indirect targeting. Here, STEAP1 is linked to posterior cortical atrophy.